Val Gebski

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.8K citations

Brca1/2 Mutation, Medicine, Cancer Management +10

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

Pedro T. Ramírez, Michael Frumovitz, René Pareja et al. · New England Journal of Medicine · 2018 · 1.8K citations · Full text

Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer

Andrew R. L. Stevenson, Michael J. Solomon, John W. Lumley et al. · JAMA · 2015 · 998 citations · Full text

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

Bryan Burmeister, B. Mark Smithers, Val Gebski et al. · The Lancet Oncology · 2005 · 928 citations

Surgical Oncology, Resectable Cancer, Esophagus +10

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma

Pierce K. H. Chow, Mihir Gandhi, Say-Beng Tan et al. · Journal of Clinical Oncology · 2018 · 625 citations